Allarity Therapeutics, Inc. (ALLR) stock
ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.79−0.08 (-9.25%)
Close on Nov 20, 2026Market cap $12.49MP/E –Yield –
Allarity Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$14.83M. The highest annual figure on record is -$7.25M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.83M | – |
| FY2024 | Dec 31, 2024 | -$17.65M | – |
| FY2023 | Dec 31, 2023 | -$12.75M | – |
| FY2022 | Dec 31, 2022 | -$16.84M | – |
| FY2020 | Dec 31, 2020 | -$7.25M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.56M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.56M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.48M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.69M | – |
See a number that looks wrong?